Early loss of renal transplants in patients with thrombophilia

Transplantation

Volumn 65, Issue 7, 1998, Pages 936-939

  Fischereder, Michael ^a,b   Göhring, Peter ^a   Schneeberger, Helmut ^a   Lohse, Peter ^a   Von Appen, Kai ^a   Samtleben, Walter ^a   Schlöndorff, Detlef ^a   Land, Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY BLOOD FLOW; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOPHILIA;

ADULT; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROTEIN C; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA;

EID: 0345486986     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804150-00013     Document Type: Article

References (20)

1. Takemoto S, Terasaki PI, Cecka JM, Cho VW, Gjertson DW. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 1992; 327: 834.
2. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients: U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225.
3. Tsuchida A, Salem H, Thomson N, Hancock W. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression. J Exp Med 1992; 175: 81.
4. Dahlbäck B, Stenflo J. The protein C anticoagulant system. In: Stamatoyannopoulos G, Nienhius AW, Majerus PW, Varmus H, eds. The molecular basis of blood diseases. Philadelphia: W.B. Saunders, 1994: 599.
5. Dahlbäck B. Physiological anticoagulation: resistance to protein C and venous thromboembolism. J Clin Invest 1994; 94: 923.
6. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517.
7. Brunkwall J, Bergqvist D, Almér LO, Nilsson IM. Tissue plasminogen activator, its fast acting plasma inhibitor and protein C after renal transplantation. Thromb Res 1995; 77: 105.
8. McCall F, Conkie JA, Walker ID, Davidson JF. Measurement of protein C in plasma: a fully automated assay. Thromb Res 1987; 45: 681.
9. Tripodi A, Negri B, Bertina RM, Mannucci PM. Screening for the FV:Q506 mutation: evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost 1997; 77: 436.
10. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel Viper Venom Time for the diagnosis of Lupus anticoagulants. Blood 1986; 68: 869.
11. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185.
12. Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521.
13. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64.
14. Hillarp A, Zöller B, Dahlbäck B. Activated protein C resistance as a basis for venous thrombosis. Am J Med 1996; 101: 534.
15. van der Bom JG, Bots ML, Haverkate F, et al. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 1996; 125: 265.
16. Ribeiro S, Carvalho F, Remédio F, et al. Vascular access thrombosis and antiphospholipids in hemodialysis patients [Abstract]. J Am Soc Nephrol 1996; 7: 1418.
17. Bokarewa MI, Blomback M, Egberg N, Rosen S. A new variant of interaction between phospholipid antibodies and the protein C system. Blood Coagul Fibrinolysis 1994; 5: 37.
18. Marcen R, Pascual J, Queredea C, et al. Lupus anticoagulant and thrombosis of kidney allograft vessels. Transplant Proc 1990; 22: 1396.
19. Koester BH, Koveker GB, Potsch B, Becker HD. Hereditary thrombophilia as a cause of recurrent transplant thromboses. Chirurg 1993; 64: 809.
20. Vaziri ND, Ismail M, Martin DC, Gonzales E. Blood coagulation, fibrinolytic and inhibitory profiles in renal transplant recipients: comparison of cyclosporine and azathioprine. Int J Artif Organs 1992; 15: 365.